Qitao Yu Selected Research

Adenocarcinoma of Lung

1/2023	Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report.
1/2020	STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qitao Yu Research Topics

Disease

19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 08/2005
16	Neoplasms (Cancer) 02/2024 - 08/2005
6	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2019
4	Disease Progression 01/2023 - 12/2019
2	Adenocarcinoma of Lung 01/2023 - 01/2020
1	Brain Neoplasms (Brain Tumor) 02/2024
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2023
1	Exanthema (Rash) 10/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Nasopharyngeal Carcinoma 12/2021
1	Infections 01/2021
1	Pulmonary Hypertension 01/2021
1	Pain (Aches) 01/2021
1	Pericardial Effusion 01/2021
1	Proteinuria 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Carcinoma (Carcinomatosis) 11/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Thymoma (Thymic Carcinoma) 11/2015
1	Myasthenia Gravis 11/2015
1	HIV Infections (HIV Infection) 11/2002

Drug/Important Bio-Agent (IBA)

6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2018
5	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2021
4	LigandsIBA 02/2024 - 01/2021
4	Programmed Cell Death 1 ReceptorIBA 02/2024 - 01/2021
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2020
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2002
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2021
3	Alanine Transaminase (SGPT)IBA 10/2023 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 01/2018
2	tislelizumabIBA 02/2024 - 12/2023
2	Anaplastic Lymphoma KinaseIBA 01/2023 - 01/2020
2	aflutinibIBA 01/2023 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2021
2	AlbuminsIBA 01/2020 - 01/2020
2	Alkaline PhosphataseIBA 01/2020 - 01/2020
2	Bevacizumab (Avastin)FDA Link 12/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 08/2005
1	Apoptosis Regulatory ProteinsIBA 02/2024
1	Cytokine Receptors (Cytokine Receptor)IBA 02/2024
1	CrizotinibIBA 01/2023
1	darifenacin FDA Link 10/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2022
1	PlatinumIBA 01/2022
1	AfatinibIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	camrelizumabIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Pemetrexed (MTA)FDA Link 10/2020
1	alectinibIBA 01/2020
1	Monoclonal AntibodiesIBA 12/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2019
1	Biosimilar PharmaceuticalsIBA 12/2019
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	nedaplatinIBA 11/2018
1	Docetaxel (Taxotere)FDA Link 11/2018
1	wogonosideIBA 10/2018
1	Long Noncoding RNAIBA 01/2015
1	EndostatinsIBA 08/2005
1	thiamine triphosphorate (TTP)IBA 08/2005
1	VaccinesIBA 11/2002

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 02/2024 - 08/2005
7	Therapeutics 01/2023 - 01/2018
4	Immunotherapy 08/2023 - 01/2021
1	Plasmapheresis 11/2015
1	Radiotherapy 11/2015
1	Ligation 11/2002